Literature DB >> 213340

Clinicopathological study on 100 early gastric cancer cases.

S Arima, H Shimura.   

Abstract

Clinicopathological study was given to 100 early gastric cancer cases. The cases included 50 intramucosal lesions (m-group) and 62 submucosal lesions (sm-group), and the share is 17% of whole cases treated surgically. The sex ratio is about 2:1 (male : female). According to the classification by location, the occurrence rate of lesion on anterior wall is 18.8%. This fact suggests the impotance of roentgenscopy by compression technique and double contrast in a prone position focussed on anterior wall. In addition, endoscopy is essential in order to detect minute cancers. The rates of metastasis of early gastric cancers is 2.4% of m-group and 16.1% of sm-group. No metastasis occurs in protruded or elevated type as far as cancer cells remain within the mucosa. Once cancer cells infiltrate into the submucosa, metastasis is observed in 36%. In the present cases, 9 (9%) out of 100 cases of early gastric cancers are the multiple cases. In order to avoid oversight of cancer foci, the portion of stomach to be remained after surgery should be throughly examined prior to operation and again under direct vision after gastric incision.

Entities:  

Mesh:

Year:  1978        PMID: 213340     DOI: 10.1007/bf02774047

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  2 in total

1.  [Surgical treatment of early cancer of the stomach--with reference to an evaluation based on its growth patterns].

Authors:  K Inokuchi; M Furusawa; K Soejima; Y Sannoe; K Abe
Journal:  Nihon Rinsho       Date:  1967-07

2.  [Early gastric cancer].

Authors:  T Kajitani; K Takagi
Journal:  Geka Chiryo       Date:  1967-03
  2 in total
  1 in total

1.  Evaluation of clinicopathological analysis of the early gastric cancer.

Authors:  M Sowa; H Ohkita; M Nitta; T Yoshimoto; H Matsuzawa; A Miki; S Sugano; T Aoki; K Kamino; K Umeyama
Journal:  World J Surg       Date:  1981-09       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.